Abbott Nutrition

Abbott Nutrition is the nutrition business of Abbott Laboratories, a United States-based healthcare company. It develops, manufactures, and markets nutritional products for several life stages and care settings, including infant and child nutrition, adult nutritional supplementation, and specialized medical nutrition. The business combines consumer-facing brands with products used or recommended in clinical and institutional environments. Its best-known brands include Similac infant formula, PediaSure pediatric nutrition products, Ensure adult nutrition products, and a portfolio of specialized formulations used in healthcare. Product availability, names, formulas, and regulatory status vary by country. Abbott Nutrition therefore operates as a broad international nutrition portfolio rather than as a single product line. The business addresses nutritional needs ranging from routine dietary supplementation to nutrition support for people with particular medical or developmental requirements. Infant and child offerings are generally positioned around age-specific growth and development, while adult products commonly emphasize supplemental calories, protein, vitamins, and minerals. Medical nutrition products are formulated for more specific dietary or clinical needs and may be distributed through hospitals, healthcare professionals, pharmacies, or specialized channels. Abbott Nutrition is part of Abbott Laboratories rather than an independent listed company. Its activities are connected to Abbott's wider healthcare capabilities, including scientific research, product development, regulatory compliance, manufacturing, quality management, and international distribution. The division's brand positioning emphasizes science-based formulation, nutritional adequacy, safety, and practical use across home and healthcare settings. The business has also been affected by the regulatory and supply-chain requirements that apply to infant formula and other nutrition products. Infant nutrition is particularly sensitive because products are consumed by vulnerable populations and are subject to detailed compositional, labeling, manufacturing, and safety rules. Abbott Nutrition's public profile has consequently included product-quality and supply-continuity issues alongside its commercial portfolio. Abbott Nutrition remains an active business within Abbott Laboratories. The available reference material does not establish a separate founding date, standalone headquarters, or independently reported financial results for the brand. Those details should therefore not be treated as distinct from Abbott Laboratories' corporate information.

Abbott Nutrition is the nutrition business operated by Abbott Laboratories. Its history is therefore closely connected with Abbott's broader development as a healthcare company rather than with a separately incorporated consumer-goods company. The business has built a portfolio spanning infant nutrition, pediatric nutrition, adult nutritional supplementation, and specialized medical nutrition. The division's consumer-facing portfolio includes products designed for different stages of life. Similac is associated primarily with infant formula, PediaSure with pediatric nutritional support, and Ensure with adult nutritional supplementation. Alongside these recognizable brands, Abbott Nutrition supplies products intended for clinical and specialized dietary use. These products may be sold through retail, pharmacy, institutional, or healthcare channels depending on their formulation and the market in which they are offered. Abbott Nutrition's operating model relies on scientific formulation, manufacturing controls, regulatory review, and international distribution. Infant formula and medical nutrition are highly regulated categories, and the applicable requirements differ across jurisdictions. Product composition, labeling, claims, and distribution arrangements can therefore vary by country. The division's international presence should not be understood as a single uniform product range. The business has occupied an important position in the United States infant-formula market. In 2022, a recall involving certain powdered infant-formula products manufactured at Abbott's Sturgis, Michigan, facility was followed by a plant shutdown and a significant supply disruption. The episode generated investigations, public criticism, litigation, and government action. Abbott later worked with regulators and other stakeholders on steps intended to resume production and improve supply availability. Because infant formula serves a particularly vulnerable population, the incident became one of the most consequential recent events associated with Abbott Nutrition. Abbott Nutrition continues to function as part of Abbott Laboratories' wider healthcare portfolio. It is not separately listed, and publicly available information does not establish a standalone founding year or separate financial reporting structure for the brand. Its present identity is best understood as an Abbott business platform that manages multiple nutrition brands and specialized product categories, supported by Abbott's research, regulatory, manufacturing, and distribution infrastructure.

• 2022

  Infant-formula recall and plant shutdown

  A recall of certain powdered infant-formula products and the temporary closure of Abbott Nutrition's Sturgis, Michigan, facility contributed to a major United States infant-formula supply disruption.

• 2022

  Measures to restore formula availability

  Abbott and public authorities pursued production, import, and distribution measures intended to improve infant-formula availability after the supply disruption.

Science-based nutrition for infants, children, adults, and patients with specialized dietary or medical needs.

• Infant formula

  Similac

  Similac is Abbott Nutrition's principal infant-formula brand. Its portfolio has included formulas for different infant feeding needs and stages, with products and formulations varying by market. Infant formula is a highly regulated category, so labeling, ingredients, permitted claims, and product availability depend on local requirements.

• Pediatric nutrition

  PediaSure

  PediaSure is a pediatric nutrition brand intended to supplement the diets of children in circumstances where additional nutrition may be required. The range is positioned around growth, development, and nutritional support, with specific products and claims differing across countries and age groups.

• Adult nutritional supplementation

  Ensure

  Ensure is Abbott Nutrition's major adult nutrition brand. It includes products marketed as supplemental sources of calories, protein, vitamins, and minerals for adults. The range is sold through consumer and healthcare-related channels, and individual products may target different dietary or nutritional requirements.

• Medical nutrition

  Medical nutrition portfolio

  Abbott Nutrition also develops specialized nutrition products for clinical and dietary applications. These products are intended for more specific nutritional circumstances than ordinary food and beverage products and may be supplied through hospitals, healthcare professionals, pharmacies, or other specialized channels.

• 2022

  Infant-formula recall and supply disruption

  Certain powdered infant-formula products associated with Abbott Nutrition were recalled, and production at the Sturgis, Michigan, facility was temporarily suspended. The event contributed to a severe United States infant-formula shortage and led to regulatory scrutiny, lawsuits, and public criticism.

Read more

• 2022

  Restart and supply-restoration measures after the formula disruptionOther

  Background

  The infant-formula recall and closure of the Sturgis facility reduced domestic supply in the United States and increased pressure on manufacturers and public authorities.

  Action taken

  Abbott worked with regulators and government stakeholders on steps intended to address the recall, resume manufacturing, and increase formula availability.

  Aftermath

  The episode remained subject to regulatory review, litigation, and continuing scrutiny of infant-formula manufacturing and supply resilience.

• 2022

  Abbott Nutrition expands infant-formula supply measures

  Other · Regulation

  Following the infant-formula shortage, Abbott and public authorities announced measures intended to restore production and increase the availability of formula products in the United States.